期刊
FUTURE MICROBIOLOGY
卷 3, 期 6, 页码 635-648出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.3.6.635
关键词
antimicrobial resistance; asthma; community-acquired pneumonia; cytadherence; enzyme-linked immunoassay; Mycoplasma pneumoniae; PCR
类别
资金
- NHLBI [P01 HL073907-04]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073907] Funding Source: NIH RePORTER
Mycoplasma pneumoniae Is a common cause of upper and lower respiratory tract Infections in persons of all ages and may be responsible for up to 40% of community-acquired pneumonias. A wide array of extrapulmonary events may accompany the infections caused by this organism, related to autommunity or direct spread. This review includes a discussion of the latest knowledge concerning the molecular pathological basis of mycoplasmal respiratory disease, how the organism interacts with the host immune system and Its association with the development of chronic conditions such as asthma, recent emergence of macrolide resistance and the status of laboratory diagnostic methods.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据